ATP5D
Gene Information
- Official Symbol: ATP5F1D
- Official Name: ATP synthase F1 subunit delta
- Aliases and Previous Symbols: N/A
- Entrez ID: 513
- UniProt: P30049
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: N/A
- UniProt Summary: Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core, and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP turnover in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Part of the complex F(1) domain and of the central stalk which is part of the complex rotary element. Rotation of the central stalk against the surrounding alpha(3)beta(3) subunits leads to hydrolysis of ATP in three separate catalytic sites on the beta subunits.
Pfam Domains GO Terms
Pfam Domains
| ATP-synt DE N |
GO Terms
| mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) |
| mitochondrial proton-transporting ATP synthase complex assembly |
| proton-transporting ATP synthase complex assembly |
| proton-transporting two-sector ATPase complex assembly |
| mitochondrial proton-transporting ATP synthase complex |
| proton-transporting ATP synthase activity, rotational mechanism |
| mitochondrial ATP synthesis coupled proton transport |
| energy coupled proton transport, down electrochemical gradient |
| ATP synthesis coupled proton transport |
| cristae formation |
| ATP biosynthetic process |
| ADP binding |
| inner mitochondrial membrane organization |
| response to copper ion |
| purine ribonucleoside triphosphate biosynthetic process |
| purine nucleoside triphosphate biosynthetic process |
| ribonucleoside triphosphate biosynthetic process |
| purine ribonucleoside triphosphate metabolic process |
| transmembrane transporter activity |
| nucleoside triphosphate biosynthetic process |
| ribonucleoside triphosphate metabolic process |
| purine nucleoside triphosphate metabolic process |
| aerobic respiration |
| mitochondrial transmembrane transport |
| nucleoside triphosphate metabolic process |
| oxidative phosphorylation |
| mitochondrial membrane organization |
| proton transmembrane transport |
| purine ribonucleotide biosynthetic process |
| purine nucleotide biosynthetic process |
| ribonucleotide biosynthetic process |
| cellular respiration |
| ribose phosphate biosynthetic process |
| purine-containing compound biosynthetic process |
| ATP metabolic process |
| mitochondrial transport |
| energy derivation by oxidation of organic compounds |
| ATPase activity |
| nucleotide biosynthetic process |
| nucleoside phosphate biosynthetic process |
| purine ribonucleotide metabolic process |
| ribonucleotide metabolic process |
| purine nucleotide metabolic process |
| ribose phosphate metabolic process |
| purine-containing compound metabolic process |
| mitochondrial matrix |
| response to metal ion |
| mitochondrial inner membrane |
| monovalent inorganic cation transport |
| generation of precursor metabolites and energy |
| mitochondrion organization |
| nucleotide metabolic process |
| nucleoside phosphate metabolic process |
| drug metabolic process |
| response to inorganic substance |
| organophosphate biosynthetic process |
| nucleobase-containing small molecule metabolic process |
| inorganic cation transmembrane transport |
| cation transmembrane transport |
| carbohydrate derivative biosynthetic process |
| inorganic ion transmembrane transport |
| cation transport |
| cellular protein-containing complex assembly |
| membrane organization |
| organophosphate metabolic process |
| ion transmembrane transport |
| oxidation-reduction process |
| carbohydrate derivative metabolic process |
| nucleobase-containing compound biosynthetic process |
| heterocycle biosynthetic process |
| aromatic compound biosynthetic process |
| mitochondrion |
| transmembrane transport |
| phosphorylation |
| organic cyclic compound biosynthetic process |
| ion transport |
| organonitrogen compound biosynthetic process |
| ATP binding |
| intracellular transport |
| protein-containing complex assembly |
| cellular nitrogen compound biosynthetic process |
| small molecule metabolic process |
| establishment of localization in cell |
| protein-containing complex subunit organization |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
Most Correlated Genes in Chemogenomics
| Gene | Correlation |
|---|---|
| ATP5A1 | 0.776 |
| ATP5B | 0.767 |
| ATP5O | 0.73 |
| ATP5C1 | 0.69 |
| HSD17B10 | 0.609 |
| BCS1L | 0.587 |
| ATP5H | 0.586 |
| MRPL21 | 0.585 |
| ATP5L | 0.583 |
| GATC | 0.581 |
| ATP5E | 0.576 |
| TMEM242 | 0.572 |
| ATP5I | 0.572 |
| DARS2 | 0.56 |
| ATP5F1 | 0.559 |
| ATP5J | 0.555 |
| COX16 | 0.543 |
| SELRC1 | 0.541 |
| PARS2 | 0.539 |
| SUPV3L1 | 0.538 |
| YARS2 | 0.538 |
| ATP5J2 | 0.537 |
| DOHH | 0.536 |
| DAP3 | 0.533 |
| OPA1 | 0.531 |
| WBSCR16 | 0.529 |
| SLC25A26 | 0.525 |
| MRPL23 | 0.525 |
| PDSS1 | 0.521 |
| TRIAP1 | 0.515 |
| PNPT1 | 0.515 |
| MRPS21 | 0.514 |
| MRPS14 | 0.513 |
| PMM2 | 0.511 |
| FASTKD5 | 0.51 |
| C17orf89 | 0.508 |
| MRPS34 | 0.508 |
| FH | 0.508 |
| MRPS5 | 0.503 |
| PPA2 | 0.501 |
| TARS2 | 0.5 |
| SCO2 | 0.498 |
| RPUSD4 | 0.498 |
| MRPS26 | 0.498 |
| SLC25A3 | 0.497 |
| MRP63 | 0.497 |
| QRSL1 | 0.496 |
| MRPS6 | 0.492 |
| GFM1 | 0.491 |
| NDUFA3 | 0.491 |
| THG1L | 0.49 |
| KIAA0391 | 0.49 |
| GFM2 | 0.489 |
| MRPL47 | 0.488 |
| VARS2 | 0.488 |
| COX7B | 0.488 |
| TEFM | 0.486 |
| EARS2 | 0.484 |
| MBTPS2 | 0.483 |
| NDUFA1 | 0.482 |
| SARS2 | 0.482 |
| TUFM | 0.482 |
| MRPS18A | 0.479 |
| NDUFC2 | 0.479 |
| MRPL53 | 0.476 |
| UBE2G2 | 0.476 |
| NDUFB5 | 0.474 |
| MRPS16 | 0.471 |
| RARS2 | 0.467 |
| HARS2 | 0.466 |
| C10orf2 | 0.464 |
| TAZ | 0.461 |
| TRUB2 | 0.46 |
| NDUFB11 | 0.459 |
| NDUFAF4 | 0.459 |
| MRPL20 | 0.458 |
| ALG6 | 0.458 |
| CYCS | 0.456 |
| GFPT1 | 0.456 |
| UAP1 | 0.456 |
| NDUFB3 | 0.456 |
| HCCS | 0.454 |
| ELAC2 | 0.454 |
| LARS2 | 0.453 |
| MRPS23 | 0.453 |
| ROMO1 | 0.453 |
| DPAGT1 | 0.452 |
| DNLZ | 0.452 |
| RPIA | 0.451 |
| NARS2 | 0.451 |
| MRPS11 | 0.451 |
| MRPL34 | 0.45 |
| TRNT1 | 0.449 |
| SDHA | 0.449 |
| NDUFA2 | 0.447 |
| RNASEH1 | 0.445 |
| ALG1 | 0.444 |
| UQCRQ | 0.44 |
| MRPL15 | 0.438 |
| MRPS2 | 0.437 |
| MTG1 | 0.435 |
| FTSJ2 | 0.435 |
| MRPS25 | 0.433 |
| ATXN10 | 0.433 |
| LSM10 | 0.432 |
| DHRSX | 0.431 |
| GTPBP10 | 0.431 |
| NDUFAF7 | 0.43 |
| MINOS1 | 0.43 |
| MRPS33 | 0.43 |
| CBFB | 0.43 |
| CHCHD4 | 0.429 |
| COX17 | 0.426 |
| RBFA | 0.426 |
| UQCRC2 | 0.425 |
| SEC62 | 0.424 |
| KDSR | 0.423 |
| NDUFV1 | 0.422 |
| RPUSD3 | 0.422 |
| MARS2 | 0.422 |
| TRMT10A | 0.421 |
| NDUFB1 | 0.421 |
| MTRF1L | 0.42 |
| MRPL45 | 0.42 |
| VEZT | 0.419 |
| MRPS9 | 0.419 |
| MRPL55 | 0.418 |
| HSPD1 | 0.417 |
| MTIF3 | 0.417 |
| RTN4IP1 | 0.414 |
| PGS1 | 0.414 |
| MED16 | 0.414 |
| DNAJC3 | 0.414 |
| MTPAP | 0.413 |
| RPTOR | 0.413 |
| CRLS1 | 0.412 |
| RNMT | 0.411 |
| MRPL12 | 0.411 |
| SERF2 | 0.411 |
| CASP9 | 0.41 |
| SLC25A52 | 0.409 |
| RPP21 | 0.408 |
| COX15 | 0.408 |
| TMEM41B | 0.404 |
| NDUFS7 | 0.404 |
| TRMT61A | 0.401 |
| TMEM126B | 0.401 |
| ALG5 | 0.4 |
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 208/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 9/28 |
| blood | 3/28 |
| bone | 5/26 |
| breast | 11/33 |
| central nervous system | 12/56 |
| cervix | 3/4 |
| colorectal | 6/17 |
| esophagus | 2/13 |
| fibroblast | 0/1 |
| gastric | 7/16 |
| kidney | 6/21 |
| liver | 12/20 |
| lung | 26/75 |
| lymphocyte | 5/16 |
| ovary | 10/26 |
| pancreas | 4/24 |
| peripheral nervous system | 4/16 |
| plasma cell | 4/15 |
| prostate | 1/1 |
| skin | 4/24 |
| soft tissue | 4/9 |
| thyroid | 0/2 |
| upper aerodigestive | 8/22 |
| urinary tract | 8/29 |
| uterus | 2/5 |
Essentiality in NALM6
- Essentiality Rank: 457
- Expression level (log2 read counts): 5.45
Expression Distribution
ATP5D Expression in NALM6 Cells: 5.45